Dr. Andrew Heisler, MD

Dr. Heisler practices at Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group.

Dr. Heisler's NPI, 1043639933, was assigned on April 8, 2014. Dr. Heisler graduated from Loyola University of Chicago, Stritch School of Medicine in 2014. Dr. Heisler holds Illinois license 036142788.

Dr. Heisler's primary practice is Bronson Methodist Hospital, at 601 John Street, Kalamazoo, MI 49007 in Kalamazoo County. The practice phone is (269) 341-6000.

Dr. Heisler's primary practice is Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group. Dr. Heisler is also affiliated with Bronson Battle Creek Hospital. The medical group on file is Bronson Medical Group. Dmand AI also links Dr. Heisler to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heisler practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Heisler's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Heisler is licensed in Illinois.

CMS data shows 731 Medicare services from Dr. Heisler across 6 procedure codes in 2024, for 226 Medicare patients. Medicare paid $35,702 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 226 Medicare patients who saw Dr. Heisler in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have arthritis, and 62% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Heisler's median patient age at 70, with 70% women.

In 2024, Dr. Heisler wrote 2,442 Medicare Part D claims for 452 patients. 83% of them were for generic drugs. CMS names the drug for 2,233 of them, across 28 drugs with 11 or more claims each, at $1,744,696 in total drug cost. In 2023, CMS named 1,998 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Heisler for performance year 2024, reported as part of a group. Dr. Heisler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Heisler as offering telehealth.

Dmand AI links 8 papers to Dr. Heisler, published from 2020 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Arthritis, Rheumatoid, Antirheumatic Agents and Fibromyalgia. Dr. Heisler has published most often in J Rheumatol. Dr. Heisler's most frequent co-authors are Marcy B. Bolster, MD, Wendy Marder, MD and Tuhina Neogi, MD.

CMS Open Payments shows 388 general payments to Dr. Heisler from 24 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,821.

Dr. Heisler graduated from Loyola University of Chicago, Stritch School of Medicine in 2014.